NeoGenomics’ $230 Million Common Stock Offering and $345 Million Convertible Senior Notes Offering

Davis Polk advised the joint book-running managers in the deal. NeoGenomics, Inc. executed its $345 million aggregate principal amount of its 0.250% convertible senior notes due...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here